Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Crystal

Showing results (121-130 of 133) with videos related to

Pageof 14
Sort By:
Cancer Immunology Research|June 18, 2016
Durable Complete Response from Metastatic Melanoma after Transfer of Autologous T Cells Recognizing 10 Mutated Tumor AntigensTodd D Prickett, Jessica S Crystal, Cyrille J Cohen, et al.
Nature Medicine|February 23, 2016
Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patientsAlena Gros, Maria R Parkhurst, Eric Tran, et al.
The Journal of Clinical Investigation|September 22, 2015
Isolation of neoantigen-specific T cells from tumor and peripheral lymphocytesCyrille J Cohen, Jared J Gartner, Miryam Horovitz-Fried, et al.
HIV Medicine|March 30, 2019
Depression and all-cause mortality risk in HIV-infected and HIV-uninfected US veterans: a cohort studyK So-Armah, S K Gupta, S Kundu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 6, 2017
Characterization of an Immunogenic Mutation in a Patient with Metastatic Triple-Negative Breast CancerYasmine Assadipour, Nikolaos Zacharakis, Jessica S Crystal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 25, 2014
A pilot trial using lymphocytes genetically engineered with an NY-ESO-1-reactive T-cell receptor: long-term follow-up and correlates with responsePaul F Robbins, Sadik H Kassim, Thai L N Tran, et al.
Cancer Discovery|March 29, 2014
The ALK inhibitor ceritinib overcomes crizotinib resistance in non-small cell lung cancerLuc Friboulet, Nanxin Li, Ryohei Katayama, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2022
Neoantigen Identification and Response to Adoptive Cell Transfer in Anti-PD-1 Naïve and Experienced Patients with Metastatic MelanomaShoshana T Levi, Amy R Copeland, Shirley Nah, et al.
Science (New York, N.Y.)|November 15, 2014
Patient-derived models of acquired resistance can identify effective drug combinations for cancerAdam S Crystal, Alice T Shaw, Lecia V Sequist, et al.
Journal of Medicinal Chemistry|November 24, 2025
Discovery of CFT8634, a Potent, Selective, and Orally Bioavailable Heterobifunctional Degrader of BRD9Katrina L Jackson, Ning Yin, Roman V Agafonov, et al.
Pageof 14

Showing results (121-130 of 133) with videos related to

Sort By:
Pageof 14
Cancer Immunology Research|June 18, 2016
Durable Complete Response from Metastatic Melanoma after Transfer of Autologous T Cells Recognizing 10 Mutated Tumor AntigensTodd D Prickett, Jessica S Crystal, Cyrille J Cohen, et al.
Nature Medicine|February 23, 2016
Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patientsAlena Gros, Maria R Parkhurst, Eric Tran, et al.
The Journal of Clinical Investigation|September 22, 2015
Isolation of neoantigen-specific T cells from tumor and peripheral lymphocytesCyrille J Cohen, Jared J Gartner, Miryam Horovitz-Fried, et al.
HIV Medicine|March 30, 2019
Depression and all-cause mortality risk in HIV-infected and HIV-uninfected US veterans: a cohort studyK So-Armah, S K Gupta, S Kundu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 6, 2017
Characterization of an Immunogenic Mutation in a Patient with Metastatic Triple-Negative Breast CancerYasmine Assadipour, Nikolaos Zacharakis, Jessica S Crystal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 25, 2014
A pilot trial using lymphocytes genetically engineered with an NY-ESO-1-reactive T-cell receptor: long-term follow-up and correlates with responsePaul F Robbins, Sadik H Kassim, Thai L N Tran, et al.
Cancer Discovery|March 29, 2014
The ALK inhibitor ceritinib overcomes crizotinib resistance in non-small cell lung cancerLuc Friboulet, Nanxin Li, Ryohei Katayama, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2022
Neoantigen Identification and Response to Adoptive Cell Transfer in Anti-PD-1 Naïve and Experienced Patients with Metastatic MelanomaShoshana T Levi, Amy R Copeland, Shirley Nah, et al.
Science (New York, N.Y.)|November 15, 2014
Patient-derived models of acquired resistance can identify effective drug combinations for cancerAdam S Crystal, Alice T Shaw, Lecia V Sequist, et al.
Journal of Medicinal Chemistry|November 24, 2025
Discovery of CFT8634, a Potent, Selective, and Orally Bioavailable Heterobifunctional Degrader of BRD9Katrina L Jackson, Ning Yin, Roman V Agafonov, et al.
Pageof 14